Why has the Supplemental Guidance been issued separately rather than included in the final Guidelines?
The Supplemental Guidance focuses on assessing the effects of early lifestage exposure and includes a review of existing scientific literature on chemical effects in animals and human exposure. Because the areas of carcinogenicity, genesis of disease, and effects on susceptible life stages and populations are constantly and quickly evolving, the EPA expects that this will be the first of several supplemental guidance documents to the Guidelines. These companion documents will provide additional information on how to address certain aspects of children’s risk to the cancer causing effects of some chemicals.
Related Questions
- The revised Guidelines have included guidance notes on sampling plan for microbiological analysis. What are their purposes and factors to be considered during their application?
- What is new in the Guidelines issued in March 2005 when compared to the interim guidance provided in the July 1999 Draft Revised Guidelines?
- Why has the Supplemental Guidance been issued separately rather than included in the final Guidelines?
